Email this article HEMOSTASIOLOGICAL MONITORING DURING PREGNANCY
- Authors: Medyannikova I.V.1
-
Affiliations:
- Omsk State Medical Academy, Ministry of Health of Russia
- Issue: Vol 8, No 1 (2014)
- Pages: 47-52
- Section: LECTION
- Published: 23.11.2014
- URL: https://klinitsist.abvpress.ru/Klin/article/view/147
- DOI: https://doi.org/10.17650/1818-8338-2014-1-47-52
- ID: 147
Cite item
Full Text
Abstract
As gestation progresses, all hemostatic components show changes aimed at compensating for the expenditures associated with fetal development. Activation of the hemostatic system during pregnancy creates a premorbid background for thrombotic and hemorrhagic complications. Hemostasiological examination is one of the compulsory dispensary management stages for pregnant women. An algorithm for the diagnosis of pregnancy-associated disorders in the hemostatic system is to solve the following problems: to identify the causes of hemocoagulation disorders, to determine the risk of thrombotic and hemorrhagic disorders, to prevent obstetric complications, and to monitor antithrombotic therapy. Hemostatic monitoring in pregnant women is based on rating and special methods and includes 3 stages: early, extended, and differential.
The need for extended hemostatic examination is first determined and the direction of a search for a defective component is concretized in relation of the changes found. Interpretation of laboratory test values in terms of a female medical history and gestational age underlies the timely diagnosis, adequate treatment policy, and effective prevention of gestational complications.
Keywords
About the authors
I. V. Medyannikova
Omsk State Medical Academy, Ministry of Health of Russia
Author for correspondence.
Email: mediren@gmail.com
Russian Federation
References
Supplementary files
